# OptimizeRx Corp: Form 8-K, filed Jun 12, 2026

- Company: [OptimizeRx Corp](/companies/oprx.md) (CIK 1448431)
- Form: 8-K
- Filed: 2026-06-12
- Accepted by EDGAR: Jun 12, 2026, 16:10 ET
- Period: 2026-06-09
- Accession: 0001213900-26-068272
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1448431/000121390026068272/ea0294565-8k_optimize.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1448431/000121390026068272/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1448431/000121390026068272/ea0294565-8k_optimize.htm

Filed Jun 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-068272. Last ingested by Listed: Nov 14, 2026, 19:26 ET. No prices; not investment advice.
